Nuvalent Names Henry Pelish Chief Scientific Officer; Shares Rise-March 2024-www.financetom.com

Nuvalent Names Henry Pelish Chief Scientific Officer; Shares Rise

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Nuvalent Names Henry Pelish Chief Scientific Officer; Shares Rise

Jul 11, 2024 9:31 AM

12:10 PM EDT, 07/11/2024 (MT Newswires) -- Nuvalent ( NUVL ) said Thursday it has appointed Henry Pelish as chief scientific officer.

Pelish contributed to the formation of Nuvalent ( NUVL ) and joined as biology head in 2018, according to the company.

Shares of Nuvalent ( NUVL ) were up 3.9% in recent trading.

Price: 77.45, Change: +2.93, Percent Change: +3.93

Previous page： Investment firm Stonepeak acquires Air Transport Services Group in $3.1 billion deal Next page： Kraken Robotics Completes Demo for New KATFISH Autonomous Launch and Recovery System to Navy Customers

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Investment firm Stonepeak acquires Air Transport Services Group in $3.1 billion deal

Nov 4, 2024

Nov 4 (Reuters) - Aircraft lessor Air Transport Services Group ( ATSG ) said on Monday it was being acquired by investment firm Stonepeak in a deal valued at $3.1 billion, including debt. ...

Kraken Robotics Completes Demo for New KATFISH Autonomous Launch and Recovery System to Navy Customers

Nov 4, 2024

08:32 AM EST, 11/04/2024 (MT Newswires) -- Kraken Robotics ( KRKNF ) said Monday that it completed demonstrations for its new Autonomous Launch and Recovery System (ALARS) for the KATFISH towed synthetic aperture sonar. The company said it performed demonstrations for more than 40 naval customers and partners from October 21-25 in Halifax Harbour, Nova Scotia. This was a great...

Krystal Biotech's Q3 Net Income Falls, Revenue Rises

Nov 4, 2024

08:34 AM EST, 11/04/2024 (MT Newswires) -- Krystal Biotech ( KRYS ) reported Q3 net income Monday of $0.91 per diluted share, down from $2.79 a year earlier. Analysts polled by Capital IQ expected $0.90. Net revenue for the quarter ended Sept. 30 was $83.8 million, up from $8.6 million a year earlier. Analysts surveyed by Capital IQ expected $83.1...

--Stonepeak to Acquire Air Transport Services Group for $3.1 Billion

Nov 4, 2024

08:38 AM EST, 11/04/2024 (MT Newswires) -- Price: 21.25, Change: +3.85, Percent Change: +22.13 ...